Inhibition of Both Activated p38 Mapkα and mTORC1 Potentiates the Effect of SR1 on Promoting Hematopoietic Reconstitution of Ex Vivo Expanded Human Umbilical Cord Blood Hematopoietic Stem Cells

离体 造血 干细胞 生物 脐带血 移植 细胞生物学 mTORC1型 PI3K/AKT/mTOR通路 免疫学 癌症研究 体内 内科学 医学 信号转导 生物技术
作者
Xiao Ma,Xiaoyi Li,Peng Danyue,Huifang Wang,Lei Li,Hao Zhou,Daohong Zhou,Yi Luo,Lingbo Liu
出处
期刊:Blood [Elsevier BV]
卷期号:128 (22): 2173-2173
标识
DOI:10.1182/blood.v128.22.2173.2173
摘要

Abstract Hematopoietic stem cells (HSCs) transplantation is a curative treatment for various hematological disorders. However, its use has been limited in part by the difficulty to obtain sufficient numbers of transplantable HSCs, especially from human umbilical cord bloods (hUCBs). Ex vivo expansion of cord blood HSCs can potentially mitigate the shortfall if the expanded HSCs can maintain their stemness for long-term hematopoietic reconstitution. Our previous studies have shown that some hUCB HSCs lose their "stemness" during ex vivo expansion in part due to induction of cellular senescence via p38MAPKα(p38) or mTORC1 activation and inhibition of p38 and mTOR C1 promotes HSCs expansion (Ann Hematol. 2012; 91:813-823; Transplantation. 2014; 97:20-29). Recently, it was shown that StemRegenin 1 (SR1), an antagonist of the aryl hydrocarbon receptor (AHR), could significantly promote ex vivo expansion of HSCs, primarily via inhibition of HSCs differentiation. Therefore, we investigated whether the combination of SR1 with LY2228820 (LY) and rapamycin (Rapa) to inhibit p38 and mTOR C1, respectively, can enhance ex vivo expansion of hUBC HSCs by inhibiting HSCs differentiation and senescence. Next, we confirmed that co-inhibition of activated p38 and mTORC1 promotes SR1 induced HSCs expansion ex vivo through inhibition of senescence.Our combined culture system in 7 days led to a 16.2-fold increase for CD34+CD90+ subpopulation and a 6.1-fold increase for CD34+CD45RA- subpopulation compared to input cells (Blood,126(23):381-381) .To determine the hematopoietic reconstitution ability of the progeny of hUCB CD34+ cells expanded with inhibitors of p38, mTORC1, and AHR, we transplanted 1000 to 30000 uncultured hUCB CD34+ cells or a fraction of the final culture equivalent to 1000 to 10000 starting hUCB CD34+ cells into sub-lethally irradiated 6 to 10-week-old NOD-Prkdcscid Il2rgnull (NOG) mice. Donor cell engraftment was analyzed at 8 and 13 weeks after the transplantation. The results showed that the progeny of 10,000 hUCB CD34+ cells cultured with LY, Rapa and SR1 produced significant greater donor cell engraftment in the recipients' peripheral blood compared with the same number of un-cultured hUCB CD34+ cells (2.19-fold, p<0.01), the progeny of 10,000 hUCB CD34+ cells cultured with vehicle (2.76-fold, p<0.01), or the progeny of 10,000 hUCB CD34+ cells cultured with SR1 alone (1.72-fold, p<0.05). The similar results were also found in the recipients' bone marrow and spleen. In addition, the progeny of 3,000 hUCB CD34+ cells cultured with LY, Rapa and SR1 generated the levels of peripheral blood donor cell engraftment that similar to these produced by 30,000 un-cultured hUCB CD34+ cells and the progeny of 10,000 hUCB CD34+ cells cultured with SR1 alone. More importantly, the hUCB CD34+ cells cultured with LY, Rapa and SR1 retained multi-lineage differentiation potential as they were able to produce human B cells, myeloid cells, red blood cell progenitors, megakaryocytes, and NK cells in the recipients' bone marrow. Furthermore, hUCB CD34+ cells cultured with LY, Rapa and SR1 produced the highest levels of human HSCs (CD34+CD38-/CD34+CD90+/CD34+CD45RA- cells) engraftment compared to all other cells. Collectively, these findings suggest that the combined inhibition of p38, mTORC1 and AHR is more effective in promoting the expansion and hematopoietic reconstitution of hUBC HSCs than inhibition of p38, mTORC1 or ARH alone probably via inhibition of HSCs senescence and differentiation. This new strategy may alleviate the limitation of hUBC for transplantation in adult patients. Disclosures No relevant conflicts of interest to declare.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
初初见你完成签到,获得积分10
刚刚
3秒前
思源应助淡淡月饼采纳,获得20
3秒前
dd完成签到 ,获得积分10
4秒前
Nayvue发布了新的文献求助10
8秒前
未来的幻想完成签到,获得积分10
10秒前
Kvolu29完成签到,获得积分10
11秒前
长理物电强完成签到,获得积分10
12秒前
若安在完成签到,获得积分10
13秒前
完美世界应助潘特采纳,获得10
14秒前
拼搏问薇完成签到 ,获得积分10
14秒前
单薄乐珍完成签到 ,获得积分0
17秒前
张静枝完成签到 ,获得积分10
17秒前
六步郎完成签到,获得积分10
17秒前
啊怙纲完成签到 ,获得积分10
19秒前
量子星尘发布了新的文献求助10
21秒前
scott_zip完成签到 ,获得积分10
22秒前
gxl完成签到,获得积分0
26秒前
xxx完成签到 ,获得积分10
29秒前
29秒前
努力生活的小柴完成签到,获得积分10
31秒前
33秒前
tangyong完成签到,获得积分10
35秒前
长安发布了新的文献求助10
35秒前
SucceedIn完成签到,获得积分10
36秒前
37秒前
40秒前
海洋岩土12138完成签到 ,获得积分10
41秒前
lzz完成签到 ,获得积分10
41秒前
冬雪完成签到,获得积分10
45秒前
woommoow完成签到,获得积分10
45秒前
aaatan完成签到 ,获得积分10
45秒前
lynn完成签到,获得积分10
46秒前
ABC发布了新的文献求助10
46秒前
回忆完成签到,获得积分10
47秒前
溜了溜了完成签到,获得积分10
50秒前
萧水白完成签到,获得积分10
52秒前
马桶盖盖子完成签到 ,获得积分10
52秒前
漆漆漆漆漆完成签到,获得积分10
54秒前
xzy998应助科研通管家采纳,获得10
54秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038184
求助须知:如何正确求助?哪些是违规求助? 3575908
关于积分的说明 11373872
捐赠科研通 3305715
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892662
科研通“疑难数据库(出版商)”最低求助积分说明 815022